Since the chemical synthesis of acetylcholine (ACh) was described toward the close of the last century,'6 an extensive literature has developed in regard to its pharmacologic activity, and considerable evidence has been gathered to implicate it in some of the fundamental processes of the nervous system. Information concerning this substance appears to have been gained at first through investigative effort directed toward its general physiological properties as mediated through the autonomic nervous system. As a sequel to this phase in experimental approach, attention was focused next upon its possible r6le in peripheral nerve physiology, and, more recently, rather intense interest has developed as to its place in metabolic processes of the brain. Certain hypotheses have been advanced regarding its participation in the integral physiology of the central nervous system, and some of the manifestations of disturbed physiology as reflected in clinical problems such as epilepsy and head injury, for example, have been attributed to derangement of this aspect of metabolic function. It seems appropriate, therefore, to review the pertinent contributions in this field which serve as foundations upon which current concepts are based.
Isaac' in 1909 and Meyer' in 1912 proposed general pharmacological parallelisms between (i) choline derivatives and the parasympathetic nervous system, and (ii) adrenalin and the sympathetic nervous system.
However, formulation of a sound basis for pharmacological study of the autonomic nervous system may be properly attributed to Langley,"' who extended and developed the pioneer efforts of Gaskell' in the physiology of the "involuntary" nervous system. An appreciation of the neurochemical antagonisms existing within this system is set down in Langley's monograph, Autonomic nervous system. Much of the available information concerning the activity of the parasympathetic component up to this time, however, had been derived from observations on the effects induced by pilocarpine.
Largely through the encouragement of Dale, the chemical identification of ACh as an active principle of ergot was established by Ewins`9 '9 in 1914. The comparative biological actions of the choline derivatives, esters, ethers, and ACh were investigated extensively by Dale1' who reported on their properties in detail.
ACh and electrocortical activity Some historically important observations concerning the action of parasympathetic drugs have been made by employing the intraventricular route of administration. While studying the intraventricular effects of pituitrin, Cushing"8 noted that its action strikingly resembled that of pilocarpine. When pilocarpine was injected intraventricularly, the effects were much greater than those seen when the subcutaneous route was employed; body temperature fell appreciably, and sweating, salivation, retching, and vomiting were extremely severe at times. The mechanism was believed to involve central autonomic stimulation, being predominantly parasympathetic in character. Atropinization by the subcutaneous route or by intraventricular instillation counteracted these effects.
Intraventricular injection of ACh in unanesthetized cats '3' "" resulted almost invariably in temporary cessation of respiration followed by a sleeplike state lasting several hours. Irregularities of the heart, similar to those seen after stimulation of the central end of the vagus nerve, were observed as well.' The intraventricular route was also employed in clinical studies, where onset of nausea, sweating, and often vomiting were observed.' Other early observations on the central nervous system effects of ACh were made using the encephale isole preparation in cats." 8 In these instances, carotid injection of ACh produced increased frequency of the "Berger waves" emanating from the cortex, and electroencephalographic patterns resembling those which accompany the awakening reaction were noted.
With the development of electroencephalographic techniques, studies concerning the neuropharmacological action of acetylcholine were extended to observations on the cerebral cortex. SjdstrandTM found that changes in electrical potentials induced by strychninization of rabbit cortex were enhanced if ACh or eserine was applied before, simultaneously with, or subsequent to strychninization. Miller and his co-workers"' noted that the topical application of ACh to eserinized cortex was attended by spike discharges in the electrocorticogram and occasionally by motor responses; atropinization of these animals prevented both the electrographic and motor phenomena.
Chatfield and Dempsey"2 observed characteristic changes in the electrocorticogram of cats when various areas of eserinized cortex (somesthetic, auditory, and motor cortex) were treated with 1 per cent ACh. These changes consisted of increased spontaneous electrocortical activity, the appearance of 5 to 10 per second spike discharges and, later 20 to 30 per second low amplitude spikes which spread to certain other cortical areas. Atropinization was found to abolish interval spike potentials but not the ACh bursts per se. Brenner and Merritt7 found, however, that topical ACh in concentrations of 2.5 to 10 per cent was followed by spike discharges without resort to eserine, and that the electrographic manifestations were -not inhibited by atropine, 1 mg. per kg. They suggested that the effect of ACh and other choline derivatives upon the cerebral cortex is comparable to the action of ACh upon sympathetic ganglia and at the skeletal myoneural junction. Forster' established the relationship of focal motor phenomena of the seizure discharge with ACh-induced spike discharges in the electrocorticogram.
Kristiansen and Courtois,' by demonstrating that isolated cerebral cortex responds with rhythmic spike discharges after topical application of ACh, have excluded thalamo-cortical connections as essential for the synchronization of neuronal activity which results in spike discharges. Beckett anld Gellhorn' observed that when ACh was applied to "suppressor areas" of cat and macaque cortex, local suppression of electrocortical activity occurred and likewise loss of spontaneous or electrically induced movements. They found that ACh augmented action potentials evoked by peripheral stimulation and recorded from somesthetic receiving areas; cholinesterase (ChE) applied topically to cortex had the opposite effect. In a later study, Hyde, Beckett, and Gellhorn' reported that the effect of eserine, whether given intravenously or applied topically to the cerebral cortex, potentiated the activity of a wide group of chemically different convulsant agents and they suggested that ACh might be employed for activation of the electroencephalogram. However, Kaufman, Marshall, and Walker,' in clinical studies on activation of the electroencephalogram (EEG), failed to find any significant alteration in the pattern of the EEG after intravenous administration of ACh.
Jacksonian seizures have been produced in unanesthetized rabbits by topical application of ACh to the masticatory cortex. Eserinization of the cortex enhanced the convulsive manifestations, whereas intravenous atro-pine abolished these seizure discharges.! Marrazzi This general pattern of organization, namely, a succession of alternating cholinergic and non-cholinergic neuronal aggregates, has also been demonstrated by ChA determinations using the ascending sensory pathways of the spinal cord. The posterior roots and the tracts of the dorsal columns of the cord have been shown to be non-cholinergic, while the nuclei gracilis and cuneatus are cholinergic. Generally, the second order ascending fibers (lateral lemniscus and spinocerebellar tracts) show intermediate values of ChA activity, whereas the third order neurone of the afferent path seems to be non-cholinergic. The supraoptic nucleus possesses high ChA activity. This finding is consistent with its ease of excitation by ACh or DFP." Similarly, the caudate nucleus, red nucleus, and hippocampal formation show moderately high ChA values. An alternating system of cholinergic and non-cholinergic neurones has been shown to exist in the cerebellum and its projections as well as within relay pathways of the visual system. Species variations in ChA activity suggests that an element of caution be taken in the interpretation and acceptance of strict categorization of different chemical neuronal systems within the central nervous system. Nevertheless, additional indirect evidence for the presence of cholinergic and non-cholinergic neuronal systems within the cerebral cortex seems to be the selective inhibition of ACh-induced cortical spike discharges, by intravenous atropine sulphate and adenine nucleotides in doses which are completely ineffective in diminishing strychnine-induced spikes or in altering the level of spontaneous electrocortical activity (see below).' A Ch-atropine antagonismn within the central nervous system
The pharmacological antagonism of atropine to the muscarinic effects of ACh is well known."4 Atropinization of an animal will prevent the development of spike potentials which usually follows the topical application of ACh to cerebral cortex.'6 Intraventricular injection of atropine in conjunction with ACh does not result in spike discharges usually seen when ACh is given alone.' However, others have found that atropinization (1 mg./kg.) failed to counteract the effects of ACh applied topically or injected into the subarachnoid cisterns, and they have concluded that its action upon cerebral cortex more closely resembled that upon sympathetic ganglia and parasympathetic end organs.7 Other experimental observations indicate that this atropinizing dose is relatively ineffecive for ACh antagonism and that greater doses (2-5 mg./kg.) are necessary for the inhibition of AChinduced spike discharges without necessarily causing depression of spoIltaneous electrocortical activity. ' The clinical studies of Williams' demonstrate that atropine inhibits the frequency or ease of induction of petit mal attacks precipitated by the injection of eserine or ACh in patients with petit mal epilepsy. Another interesting phenomenon, although by no means completely understood, is the clinical and subjective improvement which occurs in the Parkinsonian syndrome following the use of atropine or related compounds. The site of the pathological process in this disorder is usually located in the basal ganglia which have been shown to be predominantly cholinergic." It seems reasonable to speculate on the possibility of a derangement of ACh metabolism as the underlying mechanism responsible for the clinical manifestations attending this syndrome. The amelioration which occurs with atropine may be related to ACh antagonism at this or other neural levels.
In recent years, studies of metabolic changes in cerebral tissue following experimental head injuries have disclosed significant alterations of fundamental neurochemical mechanisms.' Traumatized areas of cortex show appreciable increases in lactic acid and inorganic phosphate content, whereas phosphocreatine and ATP levels are decreased. The adenine nucleotides, of which ATP is the most potent member, comprise the "adenylic acid system" which serves as the chief regulatory mechanism of oxidative glucose metabolism. Bornstein' has clearly demonstrated that free ACh, which is not present normally in the cerebrospinal fluid (CSF), appears in significant amounts following experimental cerebral trauma.
There appears to be a strong correlation between the amount of ACh which appears in the CSF, and behavioral and EEG changes following experimental brain concussion. That the elaboration of free ACh following cerebral trauma is responsible for the acute paralytic state and the later excitatory phenomena may be inferred from these experimental data. Bornstein' found that atropine abolished the stupor and abnormal EEG patterns seen as sequelae of experimental brain trauma. Atropine relieved behavioral and EEG changes produced by intracisternal injection of ACh. These alterations closely simulated the manifestations following experimental head injuries described above. Tower 
Anticholinesterases
The anticholinesterases may produce states of increased electrocortical excitability comparable in many ways to those seen following topical application of ACh.'9 Although it has been generally assumed that the mechanism of action is mediated through the accumulation of undestroyed ACh, this is by no means certain.'2 However, whether the anticholinesterases excite neuronal elements directly by reason of their chemical structure, or cause inhibition of ChE by some chemical union with this substance, is still a matter of speculation. The latter mechanism probably is involved in the action of eserine, for, when this substance is applied directly to cerebral cortex, rarely is the electrocortical pattern so affected as to result in spike discharges. Similar to eserine are the mechanisms of action of DFP and tetra-ethylprophosphate (TEP) ;" however, their combination with ChE appears to be relatively irreversible.6' These agents also affect cell respiratory functions of brain tissue, and may possibly exert their effects secondarily through a disturbance in cerebral oxidative metabolism.8'
Propagation of the nerve impulse in isolated nerve preparations requires the integrity of certain metabolic processes; e.g., the phosphorylation cycle, the synthesis and breakdown of ACh by ChA and ChE. The experimental findings of Nachmansohn and Feld' indicate that DFP acts relatively slowly but progressively in inhibiting ChE, which makes determinations of ChE activity over regular intervals possible. Exposure of the stellar or proximal fin nerve on the giant axon of the squid to 0.01 molar solution of eserine has been shown to abolish the action potential, but this effect is reversible inasmuch as the state of excitability may be restored by bathing the nerve preparation in sea water.'0 However, under similar experimental conditions, DFP abolished conduction of the nerve impulse when the ChE was reduced to 3 per cent or less of the control level.9 These observations show further the integral role of ACh and ChE in the mechanism of nerve conduction. The excitability of cortical neurones is diminished by ChE and augumented by eserine; topical application of eserine and ACh to cortical suppressor areas, however, may produce a local suppression of spontaneous electrocortical activity. 2 EEG changes similar to those seen clinically in status epilepticus have been observed following injection of DFP into the common carotid artery of rabbits. These changes were associated with markedly diminished ChE activity of the cortex." ' The normal electrocortical pattern could be reestablished in these animals by atropinization. The level of ChE following the administration of DFP appears to be inversely proportional to the varying degrees of abnormality in the electrocorticogram. According to Nachmansohn and Feld,w abnormal EEG patterns were produced only after an appreciable decrease in the level of ChE activity occurred and, therefore, there seems to be a wide safety margin in the maintenance of normal neuronal excitability. Complete inactivation of ChE, however, is apparently incompatible with life.
The injection of DFP into the supraoptic nucleus results in a decrease in urine flow in dogs.'7 The mechanism is presumably one of prolonged stimulation of this nucleus by the accumulation of ACh, which results in an increased liberation of antidiuretic hormone.
DFP has received extensive investigation in clinical medicine."' This agent has been employed in the treatment of abdominal distention in conjunction with neostigmine and appears to potentiate the effect of neostigmine in relieving this condition. However, patients who received this treatment experienced untoward symptoms consisting of excessive dreaming, nightmares, paresthesias and delirium, which were found to be diminished largely by the administration of atropine. Clinical investigations have revealed that DFP causes an increase in electrocortical activity, increases in the predominant cerebral rhythms, paroxysmal irregularities of rhythm, and occasionally high voltage slow activity most marked in frontal leads. Atropine was observed to have a beneficial effect in approximately 50 per cent of their patients who showed abnormal EEG findings after administration of DFP. '9 Although the mechanism through which DFP exerts its effects upon the central nervous system is not entirely clear, the indirect evidence of atropine antagonism suggests that perhaps its action is intimately related to altered ACh metabolism.
The role of the adenine nucleotides in central nervous system metabolismn It has been shown that ATP is necessary for the in vitro synthesis of ACh, and that the energy derived from the splitting of the organic phosphate linkages of ATP is apparently utilized in this synthesis. 5 ' These findings suggest that adenine derivatives may have a place in the treatment of certain clinical disorders, i.e., seizure disturbances and head injuries. 57 The mechanism of this inhibition is not known. However, it is possible that excessive concentration of ACh may cause depletion or retard formation of ATP, allowing the neuronal pool to respond to ACh by synchronous discharge. Increasing the ATP concentration either by topical application or intravenous administration may then restore the chemical equilibrium. There is at present, however, no proof for this proposed mechanism.
The ACh content of brain has been shown to vary with its physiological state; it is elevated during sleep and anesthesia, whereas decreased levels occur during emotional excitement, convulsions, and following electrical stimulation of the brain.' The destruction and resynthesis of ACh in vivo have been found to be rapidly reversible. Attention has been directed also to the findings that during anesthesia (when ACh synthesis would be expected to be minimal), brain lactic acid level is low and the phosphocreatine level is high. During electrical stimulation or convulsions the relationships between lactic acid and phosphocreatine are reversed, possibly indicating an increase in ACh synthesis. It was felt that the increased frequency of seizures and EEG changes seen clinically in epileptic patients during the early stages of anesthesia and sleep may be due to high ACh levels in the brain resulting from minimal utilization of ACh during these states. Although the neuronal excitability under these conditions is decreased, ACh may accumulate to a level which will stimulate and discharge neuronal aggregates, whereas deeper anesthesia may interfere with metabolic processes generally and thereby prevent excessive accumulation of ACh.
The inferences gained from observations on nucleotide and ACh levels, and their correlation with physiological activity of the cortex, aid in some measure in evaluating the role of ACh in the central nervous system.
Other mediators in the central nervous system Until recent years, the role of ACh has been preeminent in discussions of the chemical theory of conduction and synaptic transmission. Then, in 1948, Hellauer and Umrath" ' postulated another as yet unidentified agent as being involved in synaptic transmission and as producing vasodilatation, including that seen on antidromic stimulation. They concluded that this "ferment" is subject to enzymatic destruction and that strychnine inhibits this process. Strychnine-induced electrocortical discharges are dissimilar to those caused by ACh: the latter produces bursts of high amplitude negative spikes occurring usually at a frequency of about 10-15 per second. Strychnine spikes are of somewhat higher amplitude, customarily accompanied by an initial positive deflection, and recur singularly usually every 5 to 10 seconds, although the frequency of firing is variable. The underlying mechanism of this firing process would seem to be different, since the action of atropine and adenine nucleotides on spike discharges induced by these two agents is quite dissimilar.
Observations on the effect of ACh on the cerebellar cortex have disclosed that ACh is relatively ineffective in inducing spike discharges.' Since high amplitude spike discharges are presumably the result of synchronous firing of neuronal groups, the closely connected cells of the cerebellar cortex would seem to provide an ideal location for such synchrony to occur. The inefficacy of ACh applied to the cerebellar cortex would seem to refute either the theory of spike production or the theory of universality of ACh transmission; but other findings such as the variability of effect of ACh on different areas of cortex seem to support the view that there may be more than one chemical mediator responsible for synaptic transmission. Mention might also be made of the variable clinical and EEG patterns observed in cryptogenic epilepsy, and of the relative specificity of drugs used in their treatment-tridione in petit mal, phenurone in psychomotor seizures, and dilantin and phenobarbital in grand mal. This near therapeutic specificity may be indicative of derangements in different chemical mechanisms involved in synaptic transmission.
Chemical theory of conduction and transmlission In 1945, Feldberg' in assessing the r6le of ACh in the CNS, outlined its status as a "central synaptic transmittor" of nerve impulses. He stated that the "presence of ACh and ChE in central nervous tissue, the ability of such tissue to synthesize ACh and to release it under certain conditions, the central effects of ACh and of eserine, all provide strong evidence in favor of the theory that the transmission across a number of synapses in the central pathway of autonomic and motor neurones occurs through the mediation of ACh." Some of the objections to the acceptance of this thesis which regards ACh as the universal central transmittor were also considered. In the ascending phylogenetic scale the more developed brains have appeared to become less dependent upon ACh metabolism in that the ability to synthesize ACh, the concentration of ChE, and the ACh content of the nervous tissue are all decreased. The finding of cholinergic and noncholinergic neurones and tracts, and a low ACh content in cerebellar cortex which is rich in synaptic relationships, throws some doubt concerning the universality of ACh in central transmission and conduction. However, important evidence against the alternative theory which considers the action current as the synaptic transmittor was cited by Feldberg,2' as follows: the inability of the impulse to cross the synapse in sympathetic ganglia when the ACh content of the nerve had been markedly reduced and the ability of the nerve to synthesize ACh had been lost, and the observation that only cholinergic fibers are able to make functional connection with sympathetic ganglia in regeneration experiments. 41 Nachmansohn in 1946,49 in regarding ACh as essential in conduction and transmission, based his theory upon the following evidence. From observations on the electric eel, the concentration of ChE in nerve tissue was found to be high enough to permit an enzymatic process whose time relations are commensurate with electric manifestations of nerve impulses.'8' The localization of ChE at those neuronal surfaces which present bioelectrical phenomena contrasts remarkably with the localization of other enzymes in the body.' The formation of ACh by ChA has been found to occur at a rapid rate. A direct proportionality between ChE activity and the voltage of current exists in the electric organ of Electophorus electricus,'2 and it is generally agreed that the high energy bonds of ATP provide the energy necessary for ACh synthesis."9 Finally, the ability of anticholinesterases to diminish and, in high concentrations, to abolish the action potential in nerve9"0 has been shown, and this adds to the necessity of an intact ACh metabolic process for impulse conduction. WhitteridgeT feels that the action of ACh in the central nervous system is mainly concerned with the "facilitation of repetitive activity, particularly in the interneurones," but he does not elaborate further on the method of production of this facilitation.
CONCLUSIONS
The neurochemical studies of Feldberg and Vogt'2 have shown that there exists within the central nervous system a pattern of chemical neuronal organization consisting of alternating cholinergic and non-cholinergic neurone pools. This relatively new concept may possibly clarify some observations upon chemically induced electrocortical activity. It has been shown that synchronous electrocortical discharges which occur following strychninization of cerebral cortex are unaffected by atropine or adenine compounds, whereas these agents inhibit cortical spike potentials caused by ACh."6 These observations may be partially explained on the basis of Feldberg's thesis concerning cholinergic and non-cholinergic neurones, in that the chemical mechanisms involved in inducing synchronous firing following strychninization may include chemical synaptic mediators other than ACh. Appropriate chemical agents may be necessary for the initiation of neuronal excitation and discharge depending upon whether the neuronal pool activated belongs predominantly to cholinergic or non-cholinergic groups. The ineffectiveness of the adenine nucleotides and atropine in depressing strychnine-induced electrocortical activity, on the other hand, may point to some other mechanism of strychnine action as suggested by Chang, who believes that this agent decreases the latency of synaptic transmission and increases the chance for synchronous neuronal firing.' It has also been suggested that strychnine increases oxidative processes in cell metabolism. 6' Recent contributions from the field of clinical medicine point to the importance of ACh metabolism in cerebral function. The genesis of cryptogenic epilepsy has been linked to disturbances in ACh metabolism, while correlations between ChE activity and EEG pattern seem to support this hypothesis.' ACh has been used to precipitate clinical seizures, whereas atropine has been shown to afford protection against seizures induced by such methods. The appearance of ACh in the CSF in appreciable amounts following severe head injury may be a secondary manifestation of the altered nucleotide metabolism which has been shown to accompany trauma to brain tissue.
The arguments upon which the mechanisms of initiation and propagation of the nerve impulse are based are somewhat weighted toward the consideration that these processes are predominantly if not wholly electrical in nature. Gerard' has pointed out many discrepancies in the arguments pointing to importance of ACh, but feels that the long duration of some synaptic potentials can only be explained on the basis of some chemical reaction which, however, may be entirely unrelated to ACh metabolism. Since energy transfer is involved in the production of the electrical manifestations of synaptic transmission and nerve conduction, it seems logical to assume that this energy must be derived from chemical reactions. It is the purpose of this review to focus attention on those investigations which have sought to uncover some of the fundamental neurochemical processes involved in central neural activity.
